BGLC BIONEXUS GENE LAB CORP
FollowCOM (common), issuer CIK 1737523
3 managers (3 13F filers) reported a position in BGLC shares at 2026-06-30, 14,385 shares in all. 2 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 3
- 13F filers
- 3
- New
- 2
- Added
- 0
- Reduced
- 1
- Sold out
- 1
- Shares held by filers
- 14,385
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 14,283 | $27K | <0.01% | new | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 101 | $197 | <0.01% | -130 | 13F-HRTimelineGroup |
| Caitong International Asset Management … | 1 | $2 | <0.01% | new | 13F-HRTimeline |